ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,133.32
      1.36%
      US Tech 100
      17,433.60
      2.09%
      Dow Jones
      38,717.25
      1.29%
      Brent Oil
      82.82
      -0.97%
      Bitcoin
      61,802.31
      4.53%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. SAB Biotherapeutics Inc (SABS)

      7. SAB Biotherapeutics Inc (SABS) News

      SABS

      SAB Biotherapeutics (SABS)

      SAB Biotherapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SABS
      DateTimeSourceHeadlineSymbolCompany
      04/16/20247:15AMGlobeNewswire Inc.SAB Biotherapeutics Provides SAB-142 Trial UpdateNASDAQ:SABSSAB Biotherapeutics Inc
      04/08/20247:15AMGlobeNewswire Inc.SAB Biotherapeutics to Present at INNODIA Annual MeetingNASDAQ:SABSSAB Biotherapeutics Inc
      04/04/20247:15AMGlobeNewswire Inc.SAB Biotherapeutics to Present at the Needham Virtual Healthcare ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
      03/29/20247:15AMGlobeNewswire Inc.SAB Biotherapeutics Reports Full Year 2023 Operating and Financial ResultsNASDAQ:SABSSAB Biotherapeutics Inc
      03/25/202410:15AMGlobeNewswire Inc.SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza TreatmentNASDAQ:SABSSAB Biotherapeutics Inc
      03/08/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      02/23/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
      02/23/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
      02/23/20248:00AMGlobeNewswire Inc.SAB Biotherapeutics to Present at the BIO CEO & Investor ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
      02/08/20248:00AMGlobeNewswire Inc.SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
      02/02/20247:53AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      02/02/20247:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Executive Leadership ChangeNASDAQ:SABSSAB Biotherapeutics Inc
      01/26/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      01/26/20244:00PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SABSSAB Biotherapeutics Inc
      01/25/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      01/23/20245:58PMGlobeNewswire Inc.SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:SABSSAB Biotherapeutics Inc
      01/19/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      01/03/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      01/02/20244:30PMGlobeNewswire Inc.SAB Biotherapeutics Announces 1-for-10 Reverse Stock SplitNASDAQ:SABSSAB Biotherapeutics Inc
      12/18/20239:34AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
      12/08/20235:26PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
      11/30/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
      11/29/20237:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      11/29/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSSAB Biotherapeutics Inc
      11/29/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SABSSAB Biotherapeutics Inc
      11/28/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
      11/28/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
      11/22/20234:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      11/20/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
      11/20/20234:45PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:SABSSAB Biotherapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:SABS